WikiLeaks’ Assange downplays health concerns

Wikileaks founder Julian Assange gestures as he appears to speak from the balcony of Ecuador's embassy in LondonLONDON (Reuters) – WikiLeaks founder Julian Assange, holed up in London's Ecuadorian embassy for nearly six months, played down concerns about his health on Thursday, saying he enjoyed being at the centre of the legal and diplomatic storm. Assange, 41, whose website angered the United States by releasing thousands of secret diplomatic cables, took sanctuary in Ecuador's embassy in June, jumping bail after exhausting appeals in British courts against extradition to Sweden for sexual assault allegations. …

Mercury, oils from fish at odds in heart health

NEW YORK (Reuters Health) – Mercury and omega-3 fatty acids – both found in fish – appear to have opposite links to heart health, scientists have found. In an analysis of more than 1,600 men from Sweden and Finland, researchers found that men with high levels of mercury in the body had an increased risk of heart attacks, while those with a high concentration of omega-3s had a lower risk. Fish are considered part of a healthy diet, but the balance between potential risks and benefits from the two compounds is not clear. …

Weight loss surgery helps prevent diabetes: study

NEW YORK (Reuters Health) – Treating obese people with weight loss surgery dramatically delays or prevents the onset of type 2 diabetes, according to a new study. “We saw a marked delay (in the development of diabetes) over 15 years,” said coauthor Dr. Lars Sjostrom of the University of Gothenburg in Sweden. “Some of those surgical patients will probably develop diabetes later. But over a lifetime, there will be a large difference.” Among the 1,658 volunteers who received surgery, mostly stomach stapling, the risk of developing diabetes was about one in 150 per year. …

AstraZeneca sales hit hard by generic competition

LONDON (Reuters) – AstraZeneca’s sales tumbled 21 percent in the second quarter, punished by generic competition to its best-selling antipsychotic medicine Seroquel and pressure on health spending in Europe. Continued supply chain disruptions triggered by problems with a new IT system at a plant in Sweden added to the group’s woes and the shares fell 1.8 percent by 04.30 a.m. EDT in a flat market for European drug stocks. …

1 2 3